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Women’s healthZika virus (ZIKV) is a single-stranded RNA arbovirus belonging
to the Flavivirus genus.1,2 Similar to other zoonotic arboviruses,
ZIKV is transmitted by the Aedes mosquito. It causes Zika fever, a
usually non-fatal condition with symptoms including headache,
fever, malaise, maculopapular rash, joint pains, and conjunctivitis.2
Recently, it was revealed that ZIKV may have additional pathogenic
effects on pregnant women and their fetuses. Reports from South
America suggest that ZIKV infection during pregnancy causes fetal
microcephaly,2 which has negative impacts up to and including
death.2,3 In addition to mosquito-borne transmission, it has been
reported that ZIKV may be transmitted through heterosexual
intercourse,2 with concomitant implications for global women’s
health. This is the ﬁrst example of a mosquito-borne arbovirus that
may also utilize a sexual route of transmission. This knowledge has
initiated a massive effort by the translational science community
to develop more effective detection methods and treatment
strategies.
Currently there are no approved vaccines or drugs for
preventing or treating ZIKV infection or ZIKV-induced pathologies.
Recent diagnostics development efforts have focused on ELISA
and highly sensitive quantitative reverse transcription PCR* Corresponding authors.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(RT-qPCR)-based detection to identify affected individuals. Viral
load assays can quantify ZIKV RNA extracted directly from patient
specimens (e.g., blood) and utilize ZIKV-speciﬁc ampliﬁcation
primers that target conserved regions of the viral genome.4,5
Another viral characterization strategy utilized by researchers
involves infection of cells that are permissive to ZIKV infection
before detection. Studies have shown that human dermal
ﬁbroblasts and placental macrophages can be directly infected
by ZIKV.6,7 By utilizing these in vitro diagnostic methods, it is
possible to characterize the systemic infection to better inform
vaccine or drug development. The objective of the current work
was to determine whether uterine ﬁbroblasts (UF), the primary
histo-architectural cell of the uterus and endometrium, are
susceptible to ZIKV infection in vitro.
Cryopreserved UF were revived as recommended by the
American Type Culture Collection (ATCC, Manassas, VA, USA)
and the cells cultured to conﬂuency using methods reported
previously.8 Individual ﬂasks of UF were then infected with either
VR-84 or VR-1843 (ATCC). The inoculum was prepared in 1:100
and 1:1000 dilutions for each strain in low serum UF medium.
Primary infection was conducted by removing growth media and
then adding the diluted inoculum to each cell preparation. Cells
were allowed to equilibrate with the virus for 3 h. Each ﬂask of UF
was then washed with phosphate buffered saline three times to
ensure efﬁcient removal of inoculum. Fresh media were added and
the cells were cultured for 5 days, with aliquots of media removed
at day 3 and day 5 to determine whether there was an incremental
increase in viral load. At day 5, UF were trypsinized, pelleted, and
frozen for RNA extraction on the QIAcube (Qiagen Inc., Valencia,
CA, USA). To detect viral presence in these cultures, RT-qPCR with
primer–probe sets that target the envelope region of the virus were
utilized. The relative expression of viral load was analyzed using
the threshold detection cycle (Ct) of each test sample normalized
to NATTROL Zika Virus Ct (see Appendix 1), an inactivated, non-
infectious molecular testing control material (ZeptoMetrix Corpo-
ration, Buffalo, NY, USA).
The results indicated that UF are susceptible to ZIKV infection
(Figure 1). At day 3 and day 5, the conditioned medium exhibited a
higher relative viral load compared to the inoculum for both strains
of ZIKV, with the greatest relative increase observed for the 1:100
dilution of MR766 African strain at both time points. The relativeciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Relative expression of Zika virus in cultured uterine ﬁbroblasts (UF)
compared to negative control. The relative viral load is calculated utilizing the
comparative cycle threshold (Ct) method. The relative levels of virus in the
inoculum for 1:100 and 1:1000 dilutions of each strain are indicated. Relative levels
of virus in the conditioned medium at day 3 and day 5 are shown. The relative
expression in UF cells at day 5 is also reported. Uninfected cells and conditioned
media were utilized as negative control.
J.C. Chen et al. / International Journal of Infectious Diseases 51 (2016) 139–140140quantitation results from pelleted cells after the removal of media
were also higher than the initial inoculum. Moreover, it was
observed that UF cells maintained viability after infection (95–99%
viability at day 5), indicating that UF cells harbor and propagate
ZIKV productively.
UF are derived from two main sources: endometrial stromal
ﬁbroblasts from the stratum functionalis, where attachment of the
embryo and exposure to female reproductive tract components
occurs, and the endometrial stratum basalis, where the systemic
exchange of molecules with the uterus transpires.9 That UF are
susceptible to infection suggests that the uterus may act as a
conduit for virus during heterosexual intercourse. Similar to
studies in placenta, the uterus could also transfer virus from the
maternal circulation to the developing fetus.
The authors acknowledge the limited scope of the experiment,
and that the detection method used has only preliminary
analytical performance parameters established. We are not aware
of previous work describing the feasibility of this mode of infection
in the female reproductive tract. These results provide support for
additional investigations into this possible path to ZIKV infection.
Furthermore, they inform the choice of cell type for infectivity
assay development as a tool in achieving effective prevention and
treatment strategies (763/800).
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Appendix 1
Infection of uterine ﬁbroblasts with ZIKV strains
Both the African founder strain (MR766) and a more recently
isolated Puerto Rico strain (PRVABC59) were tested. The inoculum
was diluted to 1:100 and 1:1000 before adding to uterine ﬁbroblast
(UF) cultures. The description indicates the compartment sampled
for RNA. The threshold detection cycle of real-time RT-qPCR (Ct)
was utilized to determine the viral load. Controls included the
positive control supplied by ZeptoMetrix (pos ctrl; the manufac-
turer did not indicate the strain used, but DNA sequencing was
utilized to conﬁrm homology to MR766), no template control (NTC,
water), and uninfected cells. Primers were designed to the
envelope region of the ZIKV MR766 African strain.
Sample ATCC# Strain Dilution Time Description Ct
Inoculum VR-84 MR766 1:100 day 0 Inoculum 16.73
Inoculum VR-84 MR766 1:1000 day 0 Inoculum 20.16
Inoculum VR-1843 PRVABC59 1:100 day 0 Inoculum 18.67
Inoculum VR-1843 PRVABC59 1:1000 day 0 Inoculum 21.65
UF cells VR-84 MR766 1:100 day 3 Supernatant 14.05
UF cells VR-84 MR766 1:1000 day 3 Supernatant 14.94
UF cells VR-1843 PRVABC59 1:100 day 3 Supernatant 15.93
UF cells VR-1843 PRVABC59 1:1000 day 3 Supernatant 19.38
UF cells VR-84 MR766 1:100 day 5 Supernatant 12.89
UF cells VR-84 MR766 1:1000 day 5 Supernatant 13.4
UF cells VR-1843 PRVABC59 1:100 day 5 Supernatant 15.07
UF cells VR-1843 PRVABC59 1:1000 day 5 Supernatant 17.34
UF cells VR-84 MR766 1:100 day 5 Cells 15.65
UF cells VR-84 MR766 1:1000 day 5 Cells 16.58
UF cells VR-1843 PRVABC59 1:100 day 5 Cells 16.85
UF cells VR-1843 PRVABC59 1:1000 day 5 Cells 17.13
Pos ctrl ZKPC ZeptoMetrix 1:1000 NA NA 19.83
NTC Water NA NA NA NA No Ct
Uninfected NA NA NA NA Cells No Ct
Uninfected NA NA NA NA Supernatant No Ct
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